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PPRECLINICAL STUDIES
Total Liquid Ventilation Provides
Ultra-Fast Cardioprotective Cooling
Renaud Tissier, DVM, PHD,* Kazutoshi Hamanaka, MD,* Atsushi Kuno, MD, PHD,*
James C. Parker, PHD,* Michael V. Cohen, MD, FACC,*† James M. Downey, PHD*
Mobile, Alabama
Objectives We tested whether total liquid ventilation (TLV) can be used to rapidly cool and protect the infarcting heart.
Background Decreasing myocardial temperature during ischemia is a powerful cardioprotective strategy, but clinical applica-
tion has been impaired by lack of practical methodology to quickly cool the heart.
Methods We performed 30-min coronary artery occlusion/3-h reperfusion in rabbits. Upon occlusion, rabbits underwent
either oxygen (Gas), normothermic liquid (Liquid Warm), or cold liquid (Liquid Cool) ventilation.
Results Left atrial chamber temperature decreased to 32.4°  0.2°C within 5 min of onset of cold TLV. Blood gases
were within acceptable limits during TLV. In the Liquid Warm group, perfluorocarbon inhalation did not alter in-
farct size compared with Gas (37.7  1.3% and 42.5  4.9% of risk zone, respectively). However, infarction was
significantly reduced in the Liquid Cool group (4.0  0.5%). Cooling only during the initial 30 min of reperfusion
did not reduce infarction.
Conclusions Total liquid ventilation can elicit rapid cardioprotective cooling during ischemia. (J Am Coll Cardiol 2007;49:
601–5) © 2007 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2006.09.041c
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1ecreased heart temperature is a powerful cardioprotective
trategy during myocardial ischemia (1–4). Even mild
yocardial hypothermia that has little hemodynamic effect
ramatically reduces infarct size in dogs (5), rabbits (1,2,6–
), pigs (4,10,11), and rats (12). Cooling appears to halt
rogression of injury during ischemia, and the sooner after
cclusion it is instituted the more effective it becomes (2).
See page 606
t is uncertain whether hypothermia instituted at reperfusion
rotects. In one study, cooling from just before reperfusion in
abbits was not protective (1), whereas in a second study by the
ame researchers it was (9). Cooling pigs just before reperfu-
ion and for 3 h thereafter was without salvage (13).
Numerous strategies for cooling the heart include skin
urface cooling (14), direct epicardial cooling with bags of iced
aline (7,9), infusion of cold saline in a closed circuit placed in
he inferior vena cava (4), passage of the blood through a heat
xchanger (2,14), and regional myocardial hypothermia with
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006, accepted September 11, 2006.losed-circuit pericardial perfusion (8). The technique most
ften investigated in humans is endovascular cooling (3,15),
ut with a cooling rate of only 2.4°C/h the target temperature
as not reached before reperfusion (15). The study was
egative. An effective cardioprotective cooling intervention
ust cool the heart rapidly so that normothermic ischemic
ime before intervention is significantly reduced.
We hypothesized that total liquid ventilation (TLV) with
ooled perfluorocarbon could elicit rapid cooling. These
iquids have a large thermal mass and excellent gas-carrier
apacity (16). The cooled perfluorocarbon should thermally
quilibrate with pulmonary blood that returns directly to the
eft heart. Partial liquid ventilation (breathing an air-
erfluorocarbon mixture) has been reported to induce hypo-
hermia in animals (17,18), and TLV (breathing only perfluo-
ocarbon) should, therefore, be even more effective for cooling.
e evaluated TLV’s ability to confer quick and cardioprotec-
ive cooling in a rabbit model of acute myocardial infarction.
ethods
urgical preparation. This study was performed in accor-
ance with the “Guide for the Care and Use of Laboratory
nimals” (National Academy Press, Washington, DC,
996) and approved by the Institutional Animal Care and
se Committee. New Zealand white rabbits anesthetized
ith sodium pentobarbital were prepared as previously de-
cribed (2). They were ventilated through a tracheotomy with
00% O2 and a positive pressure ventilator. After left thora-
otomy, a ligature was passed around a prominent branch of
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ture was measured by thermistors in
the lumen of the left atrium and
rectum, and arterial pressure was
monitored.
Experimental protocol. Five
groups of rabbits with 30-min cor-
onary artery occlusion (CAO)/3-h
reperfusion were studied. “Gas”
abbits were subjected to 100% oxygen ventilation through-
ut the procedure and maintained at 38°C. Groups 2 and 3
xperienced TLV (tidal volume of 15 ml/kg and 6 breaths/
in) throughout CAO with a target left atrial chamber
emperature of either 38°C (“Liquid Warm”) or 32°C
“Liquid Cool”) (Fig. 1). Liquid groups returned to oxygen
entilation at reperfusion, and cooled animals spontaneously
armed. A fourth group, liquid positive end-expiratory
ressure (PEEP), also had cooled TLV and was treated with
cm H2O PEEP after being returned to oxygen ventilation.
inally, in the Liquid Reperfusion group cooled TLV was
nitiated 5 min before release of the CAO and continued for
0 min of reperfusion. After 3 h of reperfusion, hearts were
emoved, and after CAO the ischemic zone was negatively
tained by fluoresccent microspheres and infarct identified
y triphenyltetrazolium staining as previously described (2).
igure 2 illustrates the design of our liquid ventilator. We
Abbreviations
and Acronyms
CAO  coronary artery
occlusion
PEEP  positive end-
expiratory pressure
TLV  total liquid ventilation
Figure 1 Experimental Protocols
B  baseline; CAO  coronary artery occlusion; CAR  coronary artery reperfusionsed a mixture of perfluorobutyltetrahydrofurane and perflu-
ropropyltetrahydropyrane (RM 101, Miteni, Milan, Italy).
tatistical analysis. Most parameters were compared by
-way analysis of variance (ANOVA) and Student-
ewman-Keuls post hoc testing. Hemodynamics were an-
lyzed by ANOVA for repeated measures. If group differ-
nces were evident, then values at 3 critical times (i.e.,
aseline, after 25 min of CAO, and after 60 min of
eperfusion) were compared with Tukey post hoc testing.
esults
ix animals completed the protocol in each group. Blood
ressure and rate-pressure product were comparable in all
roups at baseline (Table 1). Cooling decreased heart rate
nd rate-pressure product with gradual return to baseline
fter re-warming. Mean blood pressure was not signifi-
antly altered during liquid ventilation. Toward the end
f the study, atelectasis occurred in the Liquid Warm and
iquid Cool groups causing hypotension in 9 of 12
nimals. Atelectasis is a known complication of TLV if
EEP is not employed (16 –19). In rabbits receiving 2 cm
2O PEEP during oxygen breathing after TLV, blood
ressure and oxygenation were maintained throughout
eperfusion with a final mean blood pressure of 74  5
m Hg.
 positive end-expiratory pressure; Reperf  reperfusion.; PEEP
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February 6, 2007:601–5 Liquid Ventilation-Induced Cardiac HypothermiaFigure 3 shows the left atrial chamber and rectal temper-
tures for the Gas, Liquid Warm, and Liquid Cool groups.
n the Liquid Cool group, TLV induced a very rapid
ecrease in cardiac temperature. Left atrial temperature
eached target 32°C before the fifth min. Rectal temperature
eflecting core temperature decreased more slowly. During
eperfusion, temperature returned to baseline after 90 min.
t baseline, arterial blood pH and oxygen and carbon
ioxide tensions were comparable during oxygen ventilation
n all groups. Liquid ventilation after 25 min of ischemia in
Figure 2 Diagram of the Temperature-Controlled Liquid Ventilat
emodynamics
Table 1 Hemodynamics
Baseline
Is
5 min 15
Heart rate (beats/min)
Gas 235 7 247 7 243
Liquid Warm 257 8 243 8 223
Liquid Cool 245 8 184 5† 158
Liquid PEEP 281 13‡ 203 10† 179
Liquid Reperfusion 262 10 258 8 264
Mean blood pressure (mm Hg)
Gas 81 4 78 3 75
Liquid Warm 88 4 73 7 61
Liquid Cool 80 4 66 5 63
Liquid PEEP 105 8‡ 76 10† 80
Liquid Reperfusion 82 4 73 3 74
Rate-pressure product ( 100)
Gas 190 11 193 9 181
Liquid Warm 226 16 179 23 139
Liquid Cool 196 14 122 11† 100
Liquid PEEP 297 30‡ 156 24† 144
Liquid Reperfusion 215 17 189 12 196
ean SEM. Statistical significance of difference between timed observation and baseline: *p 0
aseline, 25-min ischemia, or 60-min reperfusion: ‡p 0.05. Statistical significance of differen
p 0.05.
PEEP  positive end-expiratory pressure.he Liquid Warm and Liquid Cool groups was associated
ith normal blood pH (7.38  0.02 and 7.43  0.03,
espectively) and oxygen (154  16 and 230  10 mm Hg,
espectively) and carbon dioxide (37  3 and 31  4 mm
g, respectively) tensions.
nfarct size. Figure 4 reveals that infarct size was dra-
atically reduced in the Liquid Cool and PEEP groups
ompared with the Liquid Warm and Gas groups (p 
.001). Cooling during reperfusion had no effect on
nfarct size (Fig. 4).
Reperfusion
25 min 5 min 30 min 60 min
250 15 255 10 251 9 253 8
238 6 238 12 267 5 276 9
153 4†‡§ 175 6† 215 6* 255 12
168 7†‡ 179 2† 220 6† 246 7*
264 11 198 4† 168 4† 224 6†‡
73 6 70 6 74 4 72 5
62 2 59 5* 75 4 63 8
68 2 59 5* 79 4 76 5
80 7* 76 5† 94 7 97 6‡
75 5 55 3† 56 3† 60 4†
183 22 178 18 186 14 182 16
* 162 9 139 14* 201 14 175 27
95 6†‡§ 103 12† 171 12 196 20
† 135 17† 136 9† 208 18† 241 21
200 21 109 8† 94 6† 135 11
 0.001; p 0.05. Statistical significance of difference between Gas and Liquid groups at either
een Liquid Cool and Liquid Warm at either baseline, 25-min ischemia, or 60-min reperfusion:chemia
min
 10
 8*
 6†
 6†
 10
 3
 10*
 4
 6*
 5
 8
 26
 8†
 13
 8
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ur most important finding was that TLV could elicit very
apid cardioprotective cooling in ischemic hearts. Total
iquid ventilation achieved a left atrial chamber temperature
f 32.4°C  0.2°C within 5 min. RM 101 perfluorocarbon
sed in these experiments has a much lower viscosity than
ater, but it is still higher than air. Therefore, the perfluo-
ocarbon must be actively pumped in and out of the lungs.
tudies in both animals (19,20) and humans (16) consis-
ently report a low toxicity of perfluorocarbons during
artial or TLV. These compounds are stable and inert and
Figure 3 Cardiac and Rectal Temperatures
*p  0.05 versus Gas; †p  0.05 versus Liquid (comparison made at baseline, 2
LA  left atrial; other abbreviations as in Figure 1.
Figure 4 Infarct Sizes Expressed as Percentage
of the Risk Zone Volume
Open circles  individual infarct sizes; closed circles  mean infarct size with
SEM. *p  0.05 versus both Gas and Liquid Warm groups. PEEP  positive
end-expiratory pressure; Reperf  reperfusion.to not react with living tissues because the electron-rich
uorine atoms shield the underlying carbon chain (16).
lthough several clinical trials with partial liquid ventilation
ave not shown a statistically significant therapeutic benefit
n acute respiratory distress syndrome (16), they did dem-
nstrate that this material could be used safely in humans.
ecause of a lack of a suitable clinical indication, TLV has
ot yet been performed in adult humans, although it was
ested in one pediatric trial (21).
Several reports have claimed intravenous administration
f perfluorocarbon could limit infarct size (22–25), but we
aw no protection with TLV unless it was accompanied by
ooling. The mechanism of cardioprotection by cooling
emains poorly understood, but reduced cardiac metabolism
s the most likely mechanism. Hypothermia decreases the rate
f high-energy phosphate (26) and glucose (27) utilization as
ell as lactate accumulation (27). A recent nuclear magnetic
esonance study in newborn rabbit hearts confirmed that
ooling favorably altered heart metabolism during ischemia/
eperfusion (28). This study was designed to evaluate the
ffectiveness of TLV, and not to study mechanism or intracel-
ular signaling. These issues will be addressed in the future.
linical implications. The accumulated data reveal that
he degree of protection from cooling is essentially propor-
ional to the reduction in normothermic ischemic time
1,2,7), whereas cooling restricted to reperfusion is futile.
emperature-controlled TLV is a promising strategy that
ould be instituted in patients with acute myocardial infarc-
of ischemia, and 60 min of reperfusion).5 minion being prepared for percutaneous coronary intervention.
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February 6, 2007:601–5 Liquid Ventilation-Induced Cardiac Hypothermiahether these patients would reap enough benefit to justify
nesthesia and intubation depends on the delay between
iagnosis and reperfusion. If the delay were more than an
our, the benefit could be substantial. In American
ospitals door-to-balloon times exceeded 120 min in
1.5% of patients admitted during off-hours (29). During
egular hours, 27.7% still had delays in excess of 120 min.
ooling could also be attractive in patients who have to
e transferred to a different hospital for definitive intervention.
eprint requests and correspondence: Dr. James M. Downey,
epartment of Physiology, MSB 3074, University of South
labama, College of Medicine, Mobile, Alabama 36688. E-mail:
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